These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26546682)

  • 1. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis.
    Poisson LM; Suhail H; Singh J; Datta I; Denic A; Labuzek K; Hoda MN; Shankar A; Kumar A; Cerghet M; Elias S; Mohney RP; Rodriguez M; Rattan R; Mangalam AK; Giri S
    J Biol Chem; 2015 Dec; 290(52):30697-712. PubMed ID: 26546682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice via Metabolomics and Lipidomics.
    Lee G; Hasan M; Kwon OS; Jung BH
    Neuroscience; 2019 Sep; 416():74-87. PubMed ID: 31376423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
    Mangalam A; Poisson L; Nemutlu E; Datta I; Denic A; Dzeja P; Rodriguez M; Rattan R; Giri S
    J Clin Cell Immunol; 2013 Jun; 4():. PubMed ID: 24273690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
    Zahoor I; Suhail H; Datta I; Ahmed ME; Poisson LM; Waters J; Rashid F; Bin R; Singh J; Cerghet M; Kumar A; Hoda MN; Rattan R; Mangalam AK; Giri S
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2123265119. PubMed ID: 35700359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.
    Harbige LS; Layward L; Morris-Downes MM; Dumonde DC; Amor S
    Clin Exp Immunol; 2000 Dec; 122(3):445-52. PubMed ID: 11122253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.
    Dickens AM; Larkin JR; Davis BG; Griffin JL; Claridge TD; Sibson NR; Anthony DC
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):435-44. PubMed ID: 26155956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated fatty acids in multiple sclerosis therapy.
    Wergeland S; Torkildsen Ø; Bø L; Myhr KM
    Acta Neurol Scand Suppl; 2012; (195):70-5. PubMed ID: 23278660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphenylalaninaemia and experimental allergic encephalomyelitis.
    Mertin J; Hunt R
    J Neurol Sci; 1976 Oct; 29(2-4):351-9. PubMed ID: 978215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.
    Schmitz K; Brunkhorst R; de Bruin N; Mayer CA; Häussler A; Ferreiros N; Schiffmann S; Parnham MJ; Tunaru S; Chun J; Offermanns S; Foerch C; Scholich K; Vogt J; Wicker S; Lötsch J; Geisslinger G; Tegeder I
    Acta Neuropathol Commun; 2017 Jun; 5(1):42. PubMed ID: 28578681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis.
    Ng X; Sadeghian M; Heales S; Hargreaves IP
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
    Cervellini I; Ghezzi P; Mengozzi M
    Methods Mol Biol; 2013; 982():163-73. PubMed ID: 23456868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
    Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
    Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines.
    Fakan B; Szalardy L; Vecsei L
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis.
    Pyka-Fosciak G; Stasiolek M; Litwin JA
    Folia Histochem Cytobiol; 2018; 56(3):151-158. PubMed ID: 30187907
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Belloli S; Zanotti L; Murtaj V; Mazzon C; Di Grigoli G; Monterisi C; Masiello V; Iaccarino L; Cappelli A; Poliani PL; Politi LS; Moresco RM
    J Neuroinflammation; 2018 Feb; 15(1):33. PubMed ID: 29402285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
    Haji N; Mandolesi G; Gentile A; Sacchetti L; Fresegna D; Rossi S; Musella A; Sepman H; Motta C; Studer V; De Chiara V; Bernardi G; Strata P; Centonze D
    Exp Neurol; 2012 Oct; 237(2):296-303. PubMed ID: 22836148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
    Ramroodi N; Khani M; Ganjali Z; Javan MR; Sanadgol N; Khalseh R; Ravan H; Sanadgol E; Abdollahi M
    Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.